Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab with Chemoradiation for Advanced Head and Neck Cancer
NCT00343083Phase 2Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Dec 2004
- Primary completion
- Jun 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in squamous cell carcinoma of the head and neck (HNSCC), sponsored by University of Maryland, Baltimore. Started Dec 2004; status: completed.
02
Drugs
KL-140
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00343083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00343083.